Drugs / MMF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06468709 | Jun 2024 → Mar 2027 expected | autoimmune pancreatitis type 1 | Ruijin Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06468709 ↗ |